The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures
Open accessAbstract
BACKGROUND: Assessment of the efficiency of interventions is paramount to achieving equitable health-care systems. One key barrier to the widespread use of economic evaluations in resource allocation decisions is the absence of a widely accepted method to define cost-effectiveness thresholds to judge whether an intervention is cost-effective in a particular jurisdiction. We aimed to develop a method to estimate cost-effectiveness thresholds on the basis of health expenditures per capita and life expectancy at birth and empirically derive these thresholds for 174 countries. METHODS: We developed a conceptual framework to assess how the adoption and coverage of new interventions with a given incremental cost-effectiveness ratio will affect the rate of increase of health expenditures per capita and life expectancy at the population level. The cost-effectiveness threshold can be derived so that the effect of new interventions on the evolution of life expectancy and health expenditure per capita is set within predefined goals. To provide guidance on cost-effectiveness thresholds and secular trends for 174 countries, we projected country-level health expenditure per capita and life expectancy increases by income level based on World Bank data for the period 2010-19. FINDINGS: Cost-effectiveness thresholds per quality-adjusted life-year (QALY) ranged between US$87 (Democratic Republic of the Congo) and $95 958 (USA) and were less than 0·5 gross domestic product (GDP) per capita in 96% of low-income countries, 76% of lower-middle-income countries, 31% of upper-middle-income countries, and 26% of high-income countries. Cost-effectiveness thresholds per QALY were less than 1 GDP per capita in 168 (97%) of the 174 countries. Cost-effectiveness thresholds per life-year ranged between $78 and $80 529 and between 0·12 and 1·24 GDP per capita, and were less than 1 GDP per capita in 171 (98%) countries. INTERPRETATION: This approach, based on widely available data, can provide a useful reference for countries using economic evaluations to inform resource-allocation decisions and can enrich international efforts to estimate cost-effectiveness thresholds. Our results show lower thresholds than those currently in use in many countries. FUNDING: Institute for Clinical Effectiveness and Health Policy (IECS).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Self-citationUpdating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold
Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1405158 · Cited by 2,249
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
Woods, B., Revill, P., Sculpher, M., & Claxton, K. (2016) · Value in Health · doi:10.1016/j.jval.2016.02.017 · Cited by 884
Claxton, K., Martin, S., Soares, M., Rice, N., Spackman, E., Hinde, S., Devlin, N., Smith, P. C., & Sculpher, M. (2015) · Health Technology Assessment · doi:10.3310/hta19140 · Cited by 853
Thresholds for the cost–effectiveness of interventions: alternative approaches
Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S. (2015) · Bulletin of the World Health Organization · doi:10.2471/blt.14.138206 · Cited by 851
Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000042 · Cited by 519
Ochalek, J., Lomas, J., & Claxton, K. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2018-000964 · Cited by 334
Estimating a cost‐effectiveness threshold for the Spanish NHS
Vallejo‐Torres, L., García‐Lorenzo, B., & Serrano‐Aguilar, P. (2017) · Health Economics · doi:10.1002/hec.3633 · Cited by 311
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System
Edney, L. C., Haji Ali Afzali, H., Cheng, T. C., & Karnon, J. (2018) · PharmacoEconomics · doi:10.1007/s40273-017-0585-2 · Cited by 234
Shillcutt, S. D., Walker, D. G., Goodman, C. A., & Mills, A. J. (2009) · PharmacoEconomics · doi:10.2165/10899580-000000000-00000 · Cited by 207
Cited by
Effectiveness of stepped care for mental health disorders: An umbrella review of meta-analyses
Jeitani, A., Fahey, P. P., Gascoigne, M., Darnal, A., & Lim, D. (2024) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2024.100140 · Cited by 30
Kazi, D. S., Abdullah, A. R., Arnold, S. V., Basu, A., Bellows, B. K., Breathett, K., Chew, D. S., Cohen, D. J., DeJong, C., Heidenreich, P. A., et al. (2026) · JACC · doi:10.1016/j.jacc.2025.05.009 · Cited by 14
Metadata
- Authors
- Pichon-Riviere, A., Drummond, M., Palacios, A., Garcia-Marti, S., & Augustovski, F.
- Venue
- The Lancet Global Health
- Publisher
- Elsevier BV
- Published
- 2023-06
- Volume
- 11
- Issue
- 6
- Pages
- e833-e842
- ISSN
- 2214-109X (ISSN-L)
- OpenAlex
- W4377086619
- Cited by
- 268
- References
- 18
- FWCI
- 54.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures. https://app.cochat.ai/papers/10.1016/s2214-109x(23)00162-6
- The paper
- Pichon-Riviere, A., Drummond, M., Palacios, A., Garcia-Marti, S., & Augustovski, F. (2023). Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(23)00162-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.